UK markets close in 57 minutes
  • FTSE 100

    7,193.21
    -40.82 (-0.56%)
     
  • FTSE 250

    22,947.09
    -37.15 (-0.16%)
     
  • AIM

    1,235.95
    +6.85 (+0.56%)
     
  • GBP/EUR

    1.1829
    +0.0044 (+0.37%)
     
  • GBP/USD

    1.3731
    +0.0054 (+0.39%)
     
  • BTC-GBP

    45,202.23
    +712.58 (+1.60%)
     
  • CMC Crypto 200

    1,450.24
    -1.39 (-0.10%)
     
  • S&P 500

    4,466.99
    -4.38 (-0.10%)
     
  • DOW

    35,171.57
    -123.19 (-0.35%)
     
  • CRUDE OIL

    82.99
    +0.71 (+0.86%)
     
  • GOLD FUTURES

    1,769.60
    +1.30 (+0.07%)
     
  • NIKKEI 225

    29,025.46
    +474.56 (+1.66%)
     
  • HANG SENG

    25,409.75
    +78.75 (+0.31%)
     
  • DAX

    15,441.85
    -145.51 (-0.93%)
     
  • CAC 40

    6,656.92
    -70.60 (-1.05%)
     

Global Small Molecule Contract Development and Manufacturing Organization (CDMO) Growth Opportunities

·1-min read

This study presents Frost & Sullivan’s overall market and segment-wise revenue forecasts of the global small molecule contract development and manufacturing organization (CDMO) industry. It highlights key growth opportunities for small molecule CDMOs based on the main evolution in their business models and strategic approaches as well as those of pharmaceutical sponsors.

New York, Sept. 29, 2021 (GLOBE NEWSWIRE) -- Reportlinker.com announces the release of the report "Global Small Molecule Contract Development and Manufacturing Organization (CDMO) Growth Opportunities" - https://www.reportlinker.com/p06153223/?utm_source=GNW


The study segments the market into two categories based on product type: Active pharmaceutical ingredients (API) manufacturing (API/drug substance) and finished dosage form (FDF) manufacturing (FDF/drug product).API is further segmented into innovator and generic APIs, while FDF is segmented into oral, semi-solid/liquid, and injectable forms.

The market forecasts in this report are for 2020–2026, capturing key market developments such as capacity expansions, mergers, acquisitions, and expanding service offerings that are set to affect the overall small molecule CDMO market growth.Other discussions in the study include:
• The impact of strategic imperatives on the industry
• Growth drivers and restraints
• Comprehensive insights on the competitive landscape
• Revenue share estimates of top market participants
• Strategic analysis of market developments in service offerings and business models
• Growth opportunities for small molecule CDMOs
Author: Surbhi Gupta
Read the full report: https://www.reportlinker.com/p06153223/?utm_source=GNW

About Reportlinker
ReportLinker is an award-winning market research solution. Reportlinker finds and organizes the latest industry data so you get all the market research you need - instantly, in one place.

__________________________

CONTACT: Clare: clare@reportlinker.com US: (339)-368-6001 Intl: +1 339-368-6001


Our goal is to create a safe and engaging place for users to connect over interests and passions. In order to improve our community experience, we are temporarily suspending article commenting